Nigeria

in page functions
[French]
Nigeria
Total population (2018) 196,752,811
Birth cohort (2018) 7,417,798
Surviving Infants (surviving to 1 year per year, 2018) 6,922,833
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 69/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 109/1000
World Bank Index, IDA (2015) 3.41
Gross Nation Income (per capita US$, 2015) 2,820
Co-financing group (2018) Accelerated transition
No. of districts/territories (2017) 774

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Nigeria

Type of support

Approvals

2001-2022 (US$)
(20 Jul 2018)

Commitments

2001-2022 (US$)
(20 Jul 2018)

Disbursements

2000-2018 (US$)
(20 Jul 2018)

% Disbursed

(20 Jul 2018)
2001 2002 2003 2004 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $834,174,468 $964,696,968 $776,807,888
Health system strengthening (HSS 1) $36,337,568 $36,337,568 $30,297,040 83%
Immunisation services support (ISS) $45,704,194 $45,704,194 $44,407,837 97%
Injection Safety Devices (NVS) $5,990,500 $7,400,000 $4,349,816 73%
Injection safety support (INS) $12,630,270 $12,630,270 $12,610,218 100%
IPV (NVS) $35,541,592 $35,541,592 $34,933,355 98%
Measles SIA (NVS) $22,491,870 $22,491,870 $22,604,288 100%
Measles SIA - Operational costs (OPC) $37,207,046 $37,207,046 $37,207,046 100%
Measles-Follow-up campaign (NVS) $11,209,500 $11,209,500 $11,803,791 105%
Measles-Follow-up campaign op.costs (OPC) $15,703,035 $15,703,035 $15,699,648 100%
Meningitis A (NVS) $6,016,000 $10,582,500
Meningitis A - campaign (NVS) $55,966,777 $55,966,777 $56,057,711 100%
Meningitis A - mini catch-up campaign (NVS) $21,044,000 $21,044,000
Meningitis A - mini catch-up op.costs (OPC) $14,409,590 $14,409,590
Meningitis A - operational costs (OPC) $43,505,648 $43,505,648 $43,505,648 100%
Penta (NVS) $146,610,194 $153,921,694 $146,187,242 100%
Pneumo (NVS) $210,616,642 $277,063,642 $219,103,072 104%
Product Switch Grant (PSG) $2,049,376 $2,049,376
Rotavirus (NVS) $50,788,000 N/A
Vaccine Introduction Grant (VIG) $20,928,337 $20,928,337 $14,176,839 68%
Yellow Fever (NVS) $39,012,946 $39,012,946 $39,711,793 102%
Yellow Fever - campaign (NVS) $32,627,883 $32,627,883 $34,808,493 107%
YF - Operational costs (OPC) $18,571,500 $18,571,500 $9,344,051 50%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Nigeria DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 33%
M:F sex ratio at birth (2018) 1.06
Household survey: DTP3 coverage for male (2012) 39.40%
Household survey: DTP3 coverage for female (2012) 37.00%
Household survey: Last DTP3 survey (2012) 38%
% districts achieving > 80% DTP3 coverage (2017) 88%
% districts achieving < 50% DTP3 coverage (2017) 2%
MCV WHO/UNICEF estimates (2017) 42%

Breakdown of support

Non-vaccine support Vaccine support
27% 73%
$207,248,327 $569,559,561

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Nigeria

07 June 2018

IPV DRC 2015

Gavi Board approves funding for inactivated poliovirus vaccine until 2020

Flexible support to Nigeria and post-transition countries also approved.

06 June 2018

Gavi Board meeting, 6-7 June 2018

The Gavi Board meeting was held in Geneva, Switzerland on 6-7 June 2018.

09 May 2018

IFPW STEP

IFPW and Gavi expand leadership training for a stronger supply chain

The partnership draws on private sector support to implement an innovative training and mentorship programme for supply chain managers in Gavi-supported countries.

close icon

modal window here